Solarvest to Focus on in-House Product Expansion
Solarvest has added key personnel as part of its operational expansion program to increase production volumes.
SVA
Solarvest BioEnergy Inc. Signs Agreement for Brazil
Eversea has signed an agreement with MRF Associates Inc. to represent the company in Brazil. Under the agreement MRF will use its extensive background and relationships to introduce SVS Organic Omega-3 products and ingredients into the Brazil marketplace.
Solarvest Bioenergy Inc. Granted Patents in India And Australia
Solarvest has been granted patents in Australia and India. The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds, and compositions thereof, including fatty acids, carotenoids and fat soluble vitamins.
Solarvest BioEnergy Inc. Closes $2.29 Million Private Placement
Solarvest has closed a private placement through the issuance of 9,189,147 units (a "Unit") for gross proceeds of $2,297,286. The placement closed in two tranches: 3,465,448 Units were issued on March 26th and 5,723,699 Units were issued on April 16th, 2021.
Solarvest Announces Development Program with Scoular
Solarvest and Scoular are exploring a potential business relationship related to developing a sustainable supply of Omega-3 fatty acids, a globally important and limited resource, through a non-binding development program. The goal of the program is to develop protocols and process data for the efficient production of commercial volumes of Omega-3 fatty acids.
Solarvest Bioenergy Inc. Announces Non-Brokered Private Placement To Existing Shareholders And Other Investors
Solarvest announces a non-brokered private placement, pursuant to which the Company intends to raise gross proceeds of up to $2,000,000 through the issuance of up to 8,000,000 Units.